• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. A D-Peptide Ligand of Integrins for Simultaneously Targeting Angiogenic Blood Vasculature and Glioma

A D-Peptide Ligand of Integrins for Simultaneously Targeting Angiogenic Blood Vasculature and Glioma

来源 :2016年中国药物制剂大会、中国药学会药剂专业委员会2016年学术年会、中国化学制药工业协会固体制剂专业委员会2016年 | 被引量 : 0次 | 上传用户：mumuduck
【摘 要】
：
Objective: Although the intensive multimodal treatments,the current prognosis of glioma patients remains poor.Tumor tissue contains not only cancer cells but also neovesculature.
【作 者】
：
Ren Yachao Zhan Changyou Gao Jie Zhang Mingfei Wei Xiaoli Ying Man Liu Zining Lu Weiyue 
【机 构】
：
Department of Pharmaceutics,School of Pharmacy,Fudan University & Key Laboratory of Smart Drug Deliv
【出 处】
：
2016年中国药物制剂大会、中国药学会药剂专业委员会2016年学术年会、中国化学制药工业协会固体制剂专业委员会2016年
【发表日期】
：
2016年4期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
　　Objective: Although the intensive multimodal treatments,the current prognosis of glioma patients remains poor.Tumor tissue contains not only cancer cells but also neovesculature.
其他文献
Aptamer and PCB formulated liposomes for targeting delivery of STAT3 siRNA to lung tumor
AS1411 aptamer targets the protein nucleolin,which is over expressed on the surface of certain cancer cells.STAT3 is a signal transducer and a transcription factor,involved in cell cycle regulation.
会议
PCB liposomesAptamerInhalationSTAT3 siRNAA549 cells
CD47 peptide-modified solid lipid nanoparticles loading docetaxel with a prolonged systemic circulat
Purpose: To prepare docetaxel(DTX)-loaded,antiphagocytosis peptide(Pep CD47)-modified solid lipid nanoparticles(SLNs)with a prolonged blood circulation,and to investigate their physicochemical propert
会议
solid lipid nanoparticlesdocetaxelpeptideprolonged circulation
In vivo antitumor efficacy of novel tumor microenvironment-responsive single walled carbon nanotubes
Purpose: To evaluate the in vivo antitumor efficacy of the novel functionalized single walled carbon nanotubes(SWCNTs)loading doxorubicin(DOX)and survivin siRNA for the treatment of A549 tumor-bearing
会议
SWCNTssurvivin siRNAPEIBetainesBR2DOX
Highly Effective Chemoimmunotherapy Mediated by Erythrocyte Membrane Camouflaged Thermoresponsive Na
Chemotherapy is still the treatment modality of choice for most advanced cancers.However,for solid tumors in particular,it is often not curative.Immunotherapy is a less conventional form of therapy an
会议
Chemo-ImmunotherapyErythrocytethermospongePluronic
Preparation and evaluation of coamorphous tadalafil-dapoxetine
Purpose: Tadalafil,a PDE5 inhibitor for the treatment of erectile dysfunction,has a low oral biaoavailability due to its extremely poorly aqueous solubility.The aim of this study was to enhance its so
会议
Synergistic Antitumor Effects of Chemo-Immunotherapy Mediated by Erythrocyte Membrane coated pH resp
Nowadays,immunotherapy has become a promising strategy by manipulating patients own immune system to recognize,track and inhibit tumor.Unfortunately,with cancer progression,immunogenicity of tumor cel
会议
Chemo-ImmunotherapyErythrocytepH responsiveNanogel
Glycyrrhetinic acid receptor-mediated nanoparticles triptolide inhibition on liver cancer
会议
Preparation of Paclitaxel and Curcumin Co-dilivery System of Lipid-Coated Mesoporous Silica Nanopart
This research aims to combine traditional Chinese medicine theory with a new drug delivery system,hoping the drug carrier is characterized with a high capacity,long cycle,and targeted therapy.
会议
Mammary gland tumorPaclitaxelCurcuminMSNsDrug delivery system
Novel SN38 derivative-based liposome as anticancer prodrug
会议
SN38-PAlong-circulating liposomepharmacokineticspharmacodynamic
Preparation of sinomenine hydrochloride osmotic pump capsules and study the drug release mechanism
Objects The osmotic pump capsules of sinomenine hydrochloride were prepared with different formulas.The drug release mechanism was discussed by assessing the influences of the formula factors.
会议
sinomenine hydrochlorideenteric osmotic pump capsulesaccumulative release rate